Latest revenue
$25.3M
as of 2026-03-31
Latest net income
$1.7M
as of 2026-03-31
Net margin
6.8%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $94.6M
- Enterprise value
- $94.6M
- P/E (trailing)
- 14.9×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $20.98
- 52-wk low
- $8.67
- Beta
- —
- Shares out
- 9.4M
5-year trend
What this company does
ITEM 1. BUSINESS As used in this Annual Report, “we”, “us”, “our”, “FitLife”, “FitLife Brands”, the “Company” or “our company” refers to FitLife Brands, Inc. and all of its subsidiaries. Overview FitLife Brands, Inc. (the “Company”) is a national provider of innovative and proprietary nutritional supplements for health-conscious consumers marketed under the following brand names: (i) NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, and Metis Nutrition (together, “NDS Products”); and (ii) iSatori, BioGenetic Laboratories, and Energize (together, the "iSatori Products"). The Company distributes the NDS Products principally through franchised General Nutrition Centers, Inc. (“GNC”)…
AI summary unavailable — showing raw filing excerpt
Generated from FTLF's filing dated 2023-03-24
Key risks
ITEM 1A - Risk Factors An investment in our securities involves a high degree of risk. You should carefully consider the following information about these risks, together with the other information contained in this Annual Report, before investing in our securities. If any of the events anticipated by the risks described below occur, our results of operations and financial condition could be adversely affected, which could result in a decline in the market price of our securities, causing you to lose all or part of your investment. Risk Factors Relating to our Business and Industry The Company was profitable during the years ended December 31, 2022 and 2021. However, we may not be able to…
AI summary unavailable — showing raw filing excerpt
Generated from FTLF's filing dated 2023-03-24
Profitability
Gross margin
38.6%
11.3%Operating margin
12.4%
39.3%Net margin
7.8%
44.3%Return on equity
14.5%
41.7%Return on assets
5.9%
61.2%Leverage
Debt / equity
1.44×
131.6%Long-term debt / equity
0.75×
218.1%Debt / assets
59.0%
54.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $25.3M | +58.9% | $1.7M | -14.8% | 6.8% |
Q4 2025 2025-12-31 | $25.9M | +72.6% | $1.6M | -20.8% | 6.3% |
Q3 2025 2025-09-30 | $23.5M | +47.0% | $921.0K | -56.7% | 3.9% |
Q2 2025 2025-06-30 | $16.1M | -4.7% | $1.7M | -33.5% | 10.8% |
Q1 2025 2025-03-31 | $15.9M | -3.7% | $2.0M | -6.6% | 12.7% |
Q4 2024 2024-12-31 | $15.0M | — | $2.1M | — | 13.8% |
Q3 2024 2024-09-30 | $16.0M | +14.9% | $2.1M | +25.4% | 13.3% |
Q2 2024 2024-06-30 | $16.9M | +14.7% | $2.6M | +33.8% | 15.5% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Medicinal Chemicals & Botanical Products · SIC 2833
Your notes
Keep private notes on FTLF — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$61.7K
Insider selling
$0
Net activity
+$61.7K
Distinct insiders
3
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns FTLF
Institutional value
$6.9M
Total shares held
487.3K
Distinct holders
27
-16 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 157.4K | $2.2M | -1.8K (-1.1%) | Trimmed |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 154.6K | $2.2M | — | New |
| 3 | Mink Brook Asset Management LLC | 28.6K | $406.7K | — | New |
| 4 | VANGUARD FIDUCIARY TRUST CO | 24.9K | $354.2K | — | New |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 23.5K | $333.5K | — | New |
| 6 | STIFEL FINANCIAL CORP | 20.0K | $283.7K | -20.4K (-50.6%) | Trimmed |
| 7 | BARD ASSOCIATES INC | 20.0K | $283.5K | +2.4K (+13.5%) | Added |
| 8 | DIMENSIONAL FUND ADVISORS LP | 17.1K | $242.3K | -2.8K (-14.0%) | Trimmed |
| 9 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 13.3K | $189.2K | -2.9K (-17.7%) | Trimmed |
| 10 | Steward Partners Investment Advisory, LLC | 6.4K | $91.2K | +2.9K (+84.7%) | Added |
| 11 | RHUMBLINE ADVISERS | 4.9K | $69.5K | +64 (+1.3%) | Added |
| 12 | NEW YORK STATE COMMON RETIREMENT FUND | 4.5K | $63.4K | +0 (+0.0%) | No change |
| 13 | UBS Group AG | 3.1K | $43.9K | +191 (+6.6%) | Added |
| 14 | Vanguard Global Advisers, LLC | 2.1K | $30.0K | — | New |
| 15 | JPMORGAN CHASE & CO | 1.6K | $22.6K | -406 (-20.4%) | Trimmed |
| 16 | BNP PARIBAS FINANCIAL MARKETS | 1.5K | $21.1K | -38 (-2.5%) | Trimmed |
| 17 | WELLS FARGO & COMPANY/MN | 1.4K | $20.1K | -2.9K (-66.8%) | Trimmed |
| 18 | Police & Firemen's Retirement System of New Jersey | 1.0K | $14.5K | +0 (+0.0%) | No change |
| 19 | Ameritas Investment Partners, Inc. | 399 | $5.7K | +0 (+0.0%) | No change |
| 20 | Legal & General Group Plc | 389 | $5.5K | -78 (-16.7%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once FTLF's latest filing finishes processing.